The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Arterial Line in Trauma Resuscitation (ALTR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05996068
Recruitment Status : Recruiting
First Posted : August 16, 2023
Last Update Posted : August 16, 2023
Sponsor:
Information provided by (Responsible Party):
National Taiwan University Hospital

Brief Summary:

Accident-related deaths is the 7th leading cause of death in Taiwan, and most of them is due to trauma from falls and traffic accident. Among trauma patients, the common cause of death is from hemorrhagic shock. Thus, real-time and accurate blood pressure monitoring is important for trauma patients. Incorrect blood pressure monitoring can lead to adverse events like traumatic cardiac arrest and shock and can also delay the time for intervention (fluid resuscitation, blood transfusion and operation). The current practice of blood pressure monitoring in trauma patient is by non-invasive blood pressure monitoring, which may be incorrect and not timely. Patient's body type and peripheral perfusion can both influence the result of non-invasive blood pressure monitoring.

With continuous and correct blood pressure monitoring, the resuscitation team can give adequate and timely treatment. In some trauma centers, arterial line insertion in trauma patients is a daily practice, while the evidence is inadequate and the potential benefit in unknown.

The main purpose of this study is to investigate the application of arterial line insertion in trauma patients. The study design is a prospective before-after study to exam whether arterial line insertion in trauma patients can reduce adverse event rate like hypovolemic shock and improve patient's outcomes.


Condition or disease Intervention/treatment Phase
Major Trauma Device: arterial line Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 216 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Intervention Model Description: We use se before-after study type and only the after phase receive intervention. Before phase will retrospectively collect data from patient without arterial line intervention.
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Enhancing Trauma Resuscitation Through Arterial Line Integration: A Before-After Study
Actual Study Start Date : January 1, 2023
Estimated Primary Completion Date : December 31, 2023
Estimated Study Completion Date : December 31, 2023

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Active Comparator: trauma patients with arterial line insertion
the after phase, actively recruited patients who are eligible for arterial line insertion
Device: arterial line
insert arterial line for patients who meet major trauma criteria

No Intervention: trauma patients without arterial line insertion
the before phase, retrospectively data collection from the past



Primary Outcome Measures :
  1. composite primary endpoint (including any hypotension, vasopressors usage, any cardiac arrest in ER, Shock index ) [ Time Frame: during ER stay, up to 6 hours ]
    including any hypotension, vasopressors usage, any cardiac arrest in ER, Shock index (HR/SBP)>1


Secondary Outcome Measures :
  1. prolong ICU admission [ Time Frame: up to 7 days ]
    define as > 6 days of admission

  2. 30 days mortality rate [ Time Frame: mortality within 30 days of trauma event ]
    mortality within 30 days of trauma event

  3. volume of fluid administration [ Time Frame: during ER stay, up to 6 hours ]
    any type of fluid administration

  4. units of red blood cell transfusion [ Time Frame: during ER stay, up to 6 hours ]
    units of red blood cell transfusion



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Glasgow Coma Scale (GCS) 13 or less
  • SBP < 90 mmHg
  • Respiratory rate < 10 or > 29 breaths/min
  • Fall from height > 6 meters
  • High-Risk Auto Crash: Partial or complete ejection, intrusion > 30 cm any site, Need for extrication for entrapped patient, Death in passenger compartment
  • Rider separated from transport vehicle with significant impact
  • Penetrating injuries to head, neck, torso, and proximal extremities
  • Skull deformity, suspected skull fracture
  • Chest wall instability, deformity, or suspected flail chest
  • Suspected pelvic fracture
  • Suspected fracture of two or more proximal long bones
  • Amputation proximal to wrist or ankle
  • Active bleeding requiring a tourniquet or wound packing with continuous pressure
  • Burns in conjunction with trauma

Exclusion Criteria:

  • Pregnancy
  • Patient or family who are unable to obtain informed consent
  • Known coagulopathy that is inappropriate for arterial line insertion
  • Known peripheral arterial occlusion disease that is inappropriate for arterial line insertion
  • traumatic cardiac arrest

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05996068


Contacts
Layout table for location contacts
Contact: An-fu Lee +886-5532-3911 ext 563329 m040608@hotmail.com.tw
Contact: Ming-tai Cheng +886-5532-3911 ext 563329 jengmt1976@gmail.com

Locations
Layout table for location information
Taiwan
National Taiwan University Hospital Yunlin Branch Recruiting
Douliu, Taiwan
Contact: An-fu Lee       m040608@hotmail.com.tw   
Sponsors and Collaborators
National Taiwan University Hospital
Publications:

Layout table for additonal information
Responsible Party: National Taiwan University Hospital
ClinicalTrials.gov Identifier: NCT05996068    
Other Study ID Numbers: 202210095DINC
First Posted: August 16, 2023    Key Record Dates
Last Update Posted: August 16, 2023
Last Verified: December 2022

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by National Taiwan University Hospital:
major trauma
arterial line
resuscitation
Additional relevant MeSH terms:
Layout table for MeSH terms
Wounds and Injuries